Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Adrenergic receptors are a fallible index of adrenergic denervation hypersensitivity

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Circadian variations in plasma concentrations of cholecystokinin and gastrin in man

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Validation of suPAR turbidimetric assay on Cobas® (c502 and c702) and comparison to suPAR ELISA

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Transcerebral exchange kinetics of large neutral amino acids during acute inspiratory hypoxia in humans

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Platelet function in lung cancer patients undergoing lobectomy

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
In view of evidence that neither interindividual nor induced intra-individual variations of adrenergic receptor status are related to metabolic or haemodynamic sensitivity to adrenaline in vivo, we took an alternative approach to assessment of the relevance of adrenergic receptor measurement by measuring these in a group of subjects with well-documented adrenergic denervation hypersensitivity, patients with diabetic autonomic neuropathy. Mononuclear leukocyte beta 2-adrenergic receptor densities (and binding affinities), measured with 125I-labelled pindolol, and isoproterenol-stimulated cyclic AMP accumulation, in samples from patients with insulin-dependent diabetes mellitus (IDDM) with diabetic autonomic neuropathy (n = 8), were no different from those in samples from patients with IDDM without neuropathy (n = 8), or from non-diabetic subjects (n = 8). In addition, platelet alpha 2-adrenergic receptor densities (and binding affinities), measured with 3H-labelled yohimbine, and adrenaline-induced suppression of cyclic AMP contents did not differ among the three groups. Thus, in contrast to idiopathic autonomic failure, there is no generalized increase in adrenergic receptors in autonomic failure due to diabetic autonomic neuropathy. Regardless of the mechanism of adrenergic denervation hypersensitivity in such patients, these data provide further evidence that measurements of cellular adrenergic receptors (and adenylate cyclase) in vitro are a fallible index of sensitivity to catecholamines in vivo.
Original languageEnglish
JournalScandinavian Journal of Clinical & Laboratory Investigation
Volume51
Issue number8
Pages (from-to)659-66
Number of pages8
ISSN0036-5513
Publication statusPublished - Dec 1991

    Research areas

  • Adult, Cell Membrane, Cyclic AMP, Diabetes Mellitus, Type 1, Diabetic Neuropathies, Epinephrine, Humans, Isoproterenol, Leukocytes, Mononuclear, Middle Aged, Pindolol, Receptors, Adrenergic, Receptors, Adrenergic, alpha, Receptors, Adrenergic, beta, Yohimbine

ID: 40201128